Overview

Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study will investigate how the use of Tranexamic acid and Bacitracin applied to the bleeding site after the hemodialysis fistula needle is removed will affect Time to Clot and Infection Rate
Phase:
Phase 4
Details
Lead Sponsor:
California Institute of Renal Research
Collaborator:
Imprimis Pharmaceuticals, Inc.
Treatments:
Bacitracin
Tranexamic Acid